FibroBiologics

FibroBiologics is a biotech company in Houston, United States, founded in 2021. It has raised $25.9M across 4 rounds, most recently a $25.0M Corporate Round in December 2024.

Headquarters
Houston, Texas
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$25.9M
Last Round
$25.0M Corporate RoundDec 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

FibroBiologics is a clinical-stage cell therapy company developing fibroblast-based treatments and potential cures for chronic autoimmune and degenerative diseases. Its pipeline targets conditions including multiple sclerosis, degenerative disc disease, osteoporosis, and burns using proprietary fibroblast cell and fibroblast-derived material technologies. The company is publicly traded on Nasdaq (FBLG) and operates a dedicated research and manufacturing laboratory in Houston, Texas.

Summary

It lists 11–50 employees. It has raised $25.9M in total across 4 rounds, most recently a $25.0M Corporate Round in Dec 2024.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundDec 2024
$25.0M

Sign up to see all 4 events

Funding: Grant through Corporate Round. Amounts, valuations, and investors where available.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

FibroBiologics on Indexed.vc
<a href="https://indexed.vc/companies/fibrobiologics"><img src="https://indexed.vc/api/badge/company/fibrobiologics" alt="FibroBiologics on Indexed.vc" width="260" height="76" /></a>